- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 29, 2026 | 18.77M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 18.76M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 18.47M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $21K |
| Capex | Q1 2026 · Mar 31, 2025 | $27K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$467K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $3.86M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $21.34M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $21.42M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $2M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $4.26M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $20.17M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $23.37M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $129.61M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $128.29M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $116.27M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $117M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $10.46M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $21.26M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $37.65M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $48.62M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $56.17M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $64.72M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $167.26M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $176.92M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.12 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.12 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $3.4M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $3.25M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$495K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.2M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $396K |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$2.1M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $4.91M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $8.58M |